(Q40094003)

17 September 2017

EBV-Positive and EBV-Negative Posttransplant Diffuse Large B Cell Lymphomas Have Distinct Genomic and Transcriptomic Features (English)

1 reference

17 September 2017

0 references

J Finalet Ferreiro

1

1 reference

17 September 2017

J Morscio

2

1 reference

17 September 2017

D Dierickx

3

1 reference

17 September 2017

P Vandenberghe

4

1 reference

17 September 2017

O Gheysens

5

1 reference

17 September 2017

G Verhoef

6

1 reference

17 September 2017

M Zamani

7

1 reference

17 September 2017

T Tousseyn

8

1 reference

17 September 2017

I Wlodarska

9

1 reference

17 September 2017

language of work or name

English

0 references

publication date

18 January 2016

1 reference

American Journal of Transplantation

17 September 2017

1 reference

17 September 2017

16

1 reference

17 September 2017

2

1 reference

17 September 2017

414-425

1 reference

Characteristic Pattern of Chromosomal Imbalances in Posttransplantation Lymphoproliferative Disorders: Correlation with Histopathological Subcategories and EBV Status

17 September 2017

1 reference

Gene expression profiling of Epstein-Barr virus-positive and -negative monomorphic B-cell posttransplant lymphoproliferative disorders

21 January 2018

1 reference

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

21 January 2018

1 reference

Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction

21 January 2018

1 reference

Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways

21 January 2018

1 reference

Bcl6/Laz3 rearrangements in post-transplant lymphoproliferative disorders

21 January 2018

1 reference

The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection

21 January 2018

1 reference

Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma.

21 January 2018

1 reference

Genome-wide copy number analysis of Hodgkin Reed-Sternberg cells identifies recurrent imbalances with correlations to treatment outcome

21 January 2018

1 reference

Non-invasive detection of genomic imbalances in Hodgkin/Reed-Sternberg cells in early and advanced stage Hodgkin's lymphoma by sequencing of circulating cell-free DNA: a technical proof-of-principle study

21 January 2018

1 reference

PD-1 and its ligands in tolerance and immunity

21 January 2018

1 reference

Constitutive AP-1 activity and EBV infection induce PD-L1 in Hodgkin lymphomas and posttransplant lymphoproliferative disorders: implications for targeted therapy

21 January 2018

1 reference

PD-L1 expression is characteristic of a subset of aggressive B-cell lymphomas and virus-associated malignancies

21 January 2018

1 reference

PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma

21 January 2018

1 reference

Role of the INK4a locus in tumor suppression and cell mortality.

21 January 2018

1 reference

The molecular balancing act of p16(INK4a) in cancer and aging

21 January 2018

1 reference

p16(Ink4a) overexpression in cancer: a tumor suppressor gene associated with senescence and high-grade tumors.

21 January 2018

1 reference

FOXP1: a potential therapeutic target in cancer.

21 January 2018

1 reference

Non-IG aberrations of FOXP1 in B-cell malignancies lead to an aberrant expression of N-truncated isoforms of FOXP1.

21 January 2018

1 reference

Strong expression of FOXP1 identifies a distinct subset of diffuse large B-cell lymphoma (DLBCL) patients with poor outcome

21 January 2018

1 reference

Analysis of Epstein-Barr virus-regulated host gene expression changes through primary B-cell outgrowth reveals delayed kinetics of latent membrane protein 1-mediated NF-κB activation

21 January 2018

1 reference

p53 gene mutations are associated with poor survival in low and low-intermediate risk diffuse large B-cell lymphomas.

21 January 2018

1 reference

Clinicopathologic comparison of plasmablastic lymphoma in HIV-positive, immunocompetent, and posttransplant patients: single-center series of 25 cases and meta-analysis of 277 reported cases

21 January 2018

1 reference

Integrated copy number and gene expression profiling analysis of Epstein-Barr virus-positive diffuse large B-cell lymphoma

21 January 2018

1 reference

Post-transplant molecularly defined Burkitt lymphomas are frequently MYC-negative and characterized by the 11q-gain/loss pattern

21 January 2018

1 reference

Posttransplant lymphoproliferative disorders not associated with Epstein-Barr virus: a distinct entity?

21 January 2018

1 reference

Epstein-Barr virus-negative post-transplant lymphoproliferative disorders: a distinct entity?

21 January 2018

1 reference

Post-transplant lymphoproliferative disorders: molecular basis of disease histogenesis and pathogenesis

21 January 2018

1 reference

The Impact of EBV Status on Characteristics and Outcomes of Posttransplantation Lymphoproliferative Disorder

21 January 2018

1 reference

Single nucleotide polymorphism-arrays provide new insights in the pathogenesis of post-transplant diffuse large B-cell lymphoma

21 January 2018

1 reference

Gene Expression Profiling Reveals Clear Differences Between EBV-Positive and EBV-Negative Posttransplant Lymphoproliferative Disorders

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/AJT.13558

1 reference

17 September 2017

1 reference